Skip to main content
placeholder image

221 A randomized phase II trial of pegylated arginine deaminase (ADI-PEG 20) in patients with malignant pleural mesothelioma

Journal Article


Abstract


UOW Authors


  •   Ranson, Marie (external author)

Publication Date


  • 2006

Citation


  • Szlosarek, P. W., Fennell, D. A., Rudd, R. M., Lind, M., Ranson, M., Hackshaw, A., . . . Steele, J. P. C. (2006). 221 A randomized phase II trial of pegylated arginine deaminase (ADI-PEG 20) in patients with malignant pleural mesothelioma. Lung Cancer, 54, s54. doi:10.1016/s0169-5002(07)70297-0

Web Of Science Accession Number


Start Page


  • s54

Volume


  • 54

Abstract


UOW Authors


  •   Ranson, Marie (external author)

Publication Date


  • 2006

Citation


  • Szlosarek, P. W., Fennell, D. A., Rudd, R. M., Lind, M., Ranson, M., Hackshaw, A., . . . Steele, J. P. C. (2006). 221 A randomized phase II trial of pegylated arginine deaminase (ADI-PEG 20) in patients with malignant pleural mesothelioma. Lung Cancer, 54, s54. doi:10.1016/s0169-5002(07)70297-0

Web Of Science Accession Number


Start Page


  • s54

Volume


  • 54